Nancy A West1, B Gwen Windham2, David S Knopman2, Dean K Shibata2, Laura H Coker2, Thomas H Mosley2. 1. From the Department of Preventive Medicine (N.A.W.) and Department of Medicine (B.G.W., T.H.M.), Division of Geriatrics, University of Mississippi Medical Center, Jackson; Department of Neurology (D.S.K.), Mayo Clinic, Rochester, MN; Department of Radiology (D.K.S.), University of Washington Medical Center, Seattle; and Division of Public Health Sciences (L.H.C.), Wake Forest School of Medicine, Winston-Salem, NC. Nawest@umc.edu. 2. From the Department of Preventive Medicine (N.A.W.) and Department of Medicine (B.G.W., T.H.M.), Division of Geriatrics, University of Mississippi Medical Center, Jackson; Department of Neurology (D.S.K.), Mayo Clinic, Rochester, MN; Department of Radiology (D.K.S.), University of Washington Medical Center, Seattle; and Division of Public Health Sciences (L.H.C.), Wake Forest School of Medicine, Winston-Salem, NC.
Abstract
OBJECTIVE: To examine the association between neuroimaging features in a predominantly middle-aged cohort and risk of late-life dementia. METHODS: Cerebral MRI was performed on 1,881 individuals with no history of stroke from the Atherosclerosis Risk in Communities Study cohort in 1993 to 1995. White matter hyperintensities (WMH), ventricular size, and sulcal size were graded on a semiquantitative scale, and presence of silent cerebral infarcts was identified. In 2011 to 2013, dementia was determined from neuropsychological testing, informant interview, hospital ICD-9 codes, and death certificate dementia codes. Cox regression was used to evaluate associations between MRI findings and dementia. RESULTS: Over 20 years of follow-up, dementia developed in 279 participants (14.8%). High-grade WMH and high-grade ventricular size were independently associated with increased dementia risk (hazard ratio [HR] for WMH 1.62, 95% confidence interval [CI] 1.14-2.30; HR for ventricular size 1.46, 95% CI 1.06-2.03). There was an increased risk of dementia for diabetic participants with silent infarcts (HR 2.56, 95% CI 1.23-5.31) but not among nondiabetic participants (HR 0.87, 95% CI 0.56-1.37). Each 1-unit increase in the total number of high-grade cerebral abnormalities at baseline (count values range 0-4) showed increased dementia risk, with a considerably higher risk among diabetic participants (HR for diabetes mellitus 1.97, 95% CI 1.44-2.69; HR for no diabetes mellitus 1.20, 95% CI 1.03-1.39). CONCLUSION: In adults without evidence of clinical stroke, MRI-detected WMH and ventricular enlargement in midlife may represent markers of brain injury that increase risk for later-life cognitive impairment. The presence of diabetes mellitus may modify the association between silent infarcts and dementia.
OBJECTIVE: To examine the association between neuroimaging features in a predominantly middle-aged cohort and risk of late-life dementia. METHODS: Cerebral MRI was performed on 1,881 individuals with no history of stroke from the Atherosclerosis Risk in Communities Study cohort in 1993 to 1995. White matter hyperintensities (WMH), ventricular size, and sulcal size were graded on a semiquantitative scale, and presence of silent cerebral infarcts was identified. In 2011 to 2013, dementia was determined from neuropsychological testing, informant interview, hospital ICD-9 codes, and death certificate dementia codes. Cox regression was used to evaluate associations between MRI findings and dementia. RESULTS: Over 20 years of follow-up, dementia developed in 279 participants (14.8%). High-grade WMH and high-grade ventricular size were independently associated with increased dementia risk (hazard ratio [HR] for WMH 1.62, 95% confidence interval [CI] 1.14-2.30; HR for ventricular size 1.46, 95% CI 1.06-2.03). There was an increased risk of dementia for diabeticparticipants with silent infarcts (HR 2.56, 95% CI 1.23-5.31) but not among nondiabetic participants (HR 0.87, 95% CI 0.56-1.37). Each 1-unit increase in the total number of high-grade cerebral abnormalities at baseline (count values range 0-4) showed increased dementia risk, with a considerably higher risk among diabeticparticipants (HR for diabetes mellitus 1.97, 95% CI 1.44-2.69; HR for no diabetes mellitus 1.20, 95% CI 1.03-1.39). CONCLUSION: In adults without evidence of clinical stroke, MRI-detected WMH and ventricular enlargement in midlife may represent markers of brain injury that increase risk for later-life cognitive impairment. The presence of diabetes mellitus may modify the association between silent infarcts and dementia.
Authors: D Mungas; D Harvey; B R Reed; W J Jagust; C DeCarli; L Beckett; W J Mack; J H Kramer; M W Weiner; N Schuff; H C Chui Journal: Neurology Date: 2005-08-23 Impact factor: 9.910
Authors: R N Bryan; T A Manolio; L D Schertz; C Jungreis; V C Poirier; A D Elster; R A Kronmal Journal: AJNR Am J Neuroradiol Date: 1994-10 Impact factor: 3.825
Authors: L H Kuller; L Shemanski; T Manolio; M Haan; L Fried; N Bryan; G L Burke; R Tracy; R Bhadelia Journal: Stroke Date: 1998-02 Impact factor: 7.914
Authors: N C Yue; A M Arnold; W T Longstreth; A D Elster; C A Jungreis; D H O'Leary; V C Poirier; R N Bryan Journal: Radiology Date: 1997-01 Impact factor: 11.105
Authors: W T Longstreth; Alice M Arnold; Norman J Beauchamp; Teri A Manolio; David Lefkowitz; Charles Jungreis; Calvin H Hirsch; Daniel H O'Leary; Curt D Furberg Journal: Stroke Date: 2004-11-29 Impact factor: 7.914
Authors: T H Mosley; D S Knopman; D J Catellier; N Bryan; R G Hutchinson; C A Grothues; A R Folsom; L S Cooper; G L Burke; D Liao; M Szklo Journal: Neurology Date: 2005-06-28 Impact factor: 9.910
Authors: T A Manolio; R A Kronmal; G L Burke; V Poirier; D H O'Leary; J M Gardin; L P Fried; E P Steinberg; R N Bryan Journal: Stroke Date: 1994-02 Impact factor: 7.914
Authors: Lewis H Kuller; Oscar L Lopez; Anne Newman; Norman J Beauchamp; Greg Burke; Corinne Dulberg; Annette Fitzpatrick; Linda Fried; Mary N Haan Journal: Neuroepidemiology Date: 2003 Jan-Feb Impact factor: 3.282
Authors: Eric E Smith; Martin O'Donnell; Gilles Dagenais; Scott A Lear; Andreas Wielgosz; Mukul Sharma; Paul Poirier; Grant Stotts; Sandra E Black; Stephen Strother; Michael D Noseworthy; Oscar Benavente; Jayesh Modi; Mayank Goyal; Saima Batool; Karla Sanchez; Vanessa Hill; Cheryl R McCreary; Richard Frayne; Shofiqul Islam; Jane DeJesus; Sumathy Rangarajan; Koon Teo; Salim Yusuf Journal: Ann Neurol Date: 2015-02 Impact factor: 10.422
Authors: Justine E F Moonen; Ilya M Nasrallah; John A Detre; Sudipto Dolui; Guray Erus; Christos Davatzikos; Osorio Meirelles; R Nick Bryan; Lenore J Launer Journal: Alzheimers Dement Date: 2022-02-09 Impact factor: 16.655
Authors: Yair Mina; Tianxia Wu; Hsing-Chuan Hsieh; Dima A Hammoud; Swati Shah; Chuen-Yen Lau; Lillian Ham; Joseph Snow; Elizabeth Horne; Anuradha Ganesan; Stanley I Rapoport; Edmund C Tramont; Daniel S Reich; Brian K Agan; Avindra Nath; Bryan R Smith Journal: Neurology Date: 2021-02-26 Impact factor: 9.910
Authors: Angela C C Jochems; Susana Muñoz Maniega; Maria Del C Valdés Hernández; Gayle Barclay; Devasuda Anblagan; Lucia Ballerini; Rozanna Meijboom; Stewart Wiseman; Adele M Taylor; Janie Corley; Francesca M Chappell; Ellen V Backhouse; Michael S Stringer; David Alexander Dickie; Mark E Bastin; Ian J Deary; Simon R Cox; Joanna M Wardlaw Journal: Neuroimage Clin Date: 2022-04-26 Impact factor: 4.891
Authors: Alberto R Ramos; Noam Alperin; Sang Lee; Kevin A Gonzalez; Wassim Tarraf; Rene Hernandez-Cardenache Journal: Appl Sci (Basel) Date: 2021-06-08 Impact factor: 2.679
Authors: Tracy d'Arbeloff; Maxwell L Elliott; Annchen R Knodt; Tracy R Melzer; Ross Keenan; David Ireland; Sandhya Ramrakha; Richie Poulton; Tim Anderson; Avshalom Caspi; Terrie E Moffitt; Ahmad R Hariri Journal: Brain Commun Date: 2019-12-09